Steqeyma is now supplied as a 45mg/0.5mL solution in a single-dose vial for subcutaneous injection, allowing for weight-based dosing for pediatric patients under 60kg.

Sarepta has issued a safety update regarding Elevidys (delandistrogene moxeparvovec-rokl) following a second reported case of acute liver failure resulting in death.

Alcohol consumption intensified links between pain and negative affect in HIV-positive patients and those who underwent TKA.

Transfibular total ankle arthroplasty (TAA) seems effective and durable for end-stage ankle arthritis, according to a study published online.

Many physicians would personally prefer to avoid life-sustaining practices if they had advanced cancer or Alzheimer disease.

Integrating a previsit, electronic reproductive health questionnaire may improve contraception and pregnancy planning documentation in rheumatology practice.

Daily walking volume and walking intensity are inversely associated with the risk for chronic low back pain (LBP), according to a study.

Subcutaneous infliximab therapy alone is associated with higher immunogenicity than IV infliximab and an immunomodulator combined.

Updated recommendations are presented for providing adolescent patients with contraceptive counseling and methods.

Patients with JIA who received tofacitinib vs placebo achieved higher rates of clinically inactive disease and remission.

When discussing fertility preservation options among transgender patients, it is critical to keep barriers to access in mind.

Patients with axSpA who received UPA reported rapid and sustained improvements in total and nocturnal back pain over 12 weeks ...